everything to know about retatrutide FDA Approval Status 2026: We So Far Retatrutide Explained: Mechanism & Weight

Retrieved from Claxton, G., Rae, M., Damico, A., et al

A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide

This is especially relevant toward the end of a vial when you have drawn most doses and the remaining solution has been through weeks of refrigerator-to-counter-to-refrigerator cycles

General principles for injectable biologics include keeping the medicine refrigerated and protected from light and freezing, but your trial documentation will provide the authoritative guidance for your specific product

Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis

Cell Metab 34:12341247